Mealey's (November 13, 2018, 11:31 AM EST) -- SAN FRANCISCO — A California federal judge on Nov. 6 denied a motion by the maker of Abilify to dismiss a tardive dyskinesia injury claim based on California’s two-year statute of limitations (Ina Ann Rodman v. Otsuka America Pharmaceutical, Inc., No. 18-3732, N.D. Calif., 2018 U.S. Dist. LEXIS 190052)....